Talia Friedman1, Menahem Neuman2, Yoav Peled3, Haim Krissi4. 1. Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer, Israel. 2. Urogynecology, Department of Obstetrics and Gynecology, Western Galilee Hospital, Israel; Faculty of Medicine in the Galilee, Bar Ilan University, Safed, Israel; Assuta Medical Center of Tel Aviv and Rishon LeZion, Israel. 3. Urogynecology, Department of Obstetrics and Gynecology, Rabin Medical Center, Petach Tikva, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 4. Urogynecology, Department of Obstetrics and Gynecology, Rabin Medical Center, Petach Tikva, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: haimkr@clalit.org.il.
Abstract
OBJECTIVE: We sought to evaluate the feasibility and safety of SeraPro(®) (Serag-Wiessner, Germany), an innovative reusable suturing device for vaginal sacrospinous ligament fixation. STUDY DESIGN: We reviewed the electronic files of all women who underwent vaginal sacrospinous ligament fixation with SeraPro(®) for apical pelvic floor prolapse, with or without mesh implant, performed between April 2013 and September 2013. Preoperative demographic, clinical, operative and postoperative data were analyzed. The women were interviewed and examined before the procedure, at one month postoperatively and tele-interviewed again after three months. RESULTS: Overall, 88 women were included in the study. Fifty-three patients (60.2%) had additional anterior mesh placement, 42 (47.7%) had posterior mesh, and 16 (18.2%) had both anterior and posterior mesh insertion. Five patients (5.7%) had no mesh implant. Sixteen patients (18.2%) had an additional mid-urethral sling for the treatment of stress urinary incontinence. No significant technical difficulty was recorded at the procedures. None of the patients had significant long-term morbidity. The mean 3-month follow-up demonstrated significant anatomical and functional improvement. CONCLUSIONS: The SeraPro(®) reusable suturing device is a feasible and safe tool for sacrospinous ligament fixation during vaginal pelvic floor reconstruction.
OBJECTIVE: We sought to evaluate the feasibility and safety of SeraPro(®) (Serag-Wiessner, Germany), an innovative reusable suturing device for vaginal sacrospinous ligament fixation. STUDY DESIGN: We reviewed the electronic files of all women who underwent vaginal sacrospinous ligament fixation with SeraPro(®) for apical pelvic floor prolapse, with or without mesh implant, performed between April 2013 and September 2013. Preoperative demographic, clinical, operative and postoperative data were analyzed. The women were interviewed and examined before the procedure, at one month postoperatively and tele-interviewed again after three months. RESULTS: Overall, 88 women were included in the study. Fifty-three patients (60.2%) had additional anterior mesh placement, 42 (47.7%) had posterior mesh, and 16 (18.2%) had both anterior and posterior mesh insertion. Five patients (5.7%) had no mesh implant. Sixteen patients (18.2%) had an additional mid-urethral sling for the treatment of stress urinary incontinence. No significant technical difficulty was recorded at the procedures. None of the patients had significant long-term morbidity. The mean 3-month follow-up demonstrated significant anatomical and functional improvement. CONCLUSIONS: The SeraPro(®) reusable suturing device is a feasible and safe tool for sacrospinous ligament fixation during vaginal pelvic floor reconstruction.
Authors: Adi Y Weintraub; Masha Ben Zvi; David Yohay; Joerg Neymeyer; Yonatan Reuven; Menahem Neuman; Alex Tsivian Journal: Int Braz J Urol Date: 2017 May-Jun Impact factor: 1.541